```html

Yersinia pestis Infection (Plague) – A Comprehensive Medical Guide

Overview

Yersinia pestis is a gram‑negative bacterium that causes plague, a severe zoonotic disease historically associated with pandemics like the Black Death. Plague exists in three classic clinical forms—bubonic, septicemic, and pneumonic—each reflecting the organ system most affected. Although plague is now rare in most high‑income countries, it remains endemic in parts of Africa, Asia, and the western United States.

Who it affects: Anyone can become infected, but people who work or live near rodent‑infested areas, hunters, outdoor enthusiasts, and laboratory personnel handling the organism are at higher risk.

Global prevalence (2022‑2023 data):

• ≈ 3,000–4,000 cases reported worldwide each year, with a case‑fatality rate of 4‑15 % when treated promptly and up to 70 % without treatment. [WHO, 2023]
• ≈ 70 % of cases occur in the African continent, especially Madagascar, the Democratic Republic of Congo, and Uganda. [CDC, 2022]
• In the United States, the average annual number of reported cases is 7–10, centered in New Mexico, Arizona, Colorado, and California. [CDC, 2023]

Symptoms

Symptoms vary according to the form of plague.

Bubonic plague

• Sudden onset of fever (≥ 38.5 °C / 101.3 °F)
• Chills and headache
• Weakness and muscle aches
• Enlarged, painful lymph nodes (buboes) usually in the groin, armpit, or neck; they become tender, erythematous, and may turn black
• Rapid progression: symptoms typically appear 2–6 days after exposure

Septicemic plague

• Fever, chills, abdominal pain
• Bleeding from gums, nose, or intravenous sites
• Purpura (purple spots) on the skin
• Shock, multi‑organ failure
• May develop without any obvious buboes

Pneumonic plague

• Fever, chills, severe headache
• Dry then productive cough with bloody or frothy sputum
• Chest pain, shortness of breath
• Rapid respiratory failure within 24–48 hours if untreated
• Highly contagious via respiratory droplets

Other possible manifestations

• Encephalitis (rare) – confusion, seizures
• Heart involvement (myocarditis) in septicemic cases

Causes and Risk Factors

Primary cause

The disease is caused by infection with Yersinia pestis, transmitted to humans in three main ways:

1. Flea bite: Infected fleas (most often Xenopsylla cheopis) bite rodents, become infected, then bite humans. This is the classic route for bubonic plague.
2. Direct contact with infected animal tissue or fluids: Handling carcasses of rodents, rabbits, or domestic animals can introduce the bacteria through skin cuts or mucous membranes.
3. Inhalation of aerosolized bacteria: Person‑to‑person spread (pneumonic plague) or exposure to contaminated dust in rodent burrows.

Risk factors

• Living or working in endemic rural areas with high rodent populations.
• Occupations: wildlife biologists, pest control workers, veterinarians, laboratory staff.
• Outdoor activities in plague‑endemic regions (hiking, hunting) without proper protective clothing.
• Recent outbreaks in family or community (increased risk of pneumonic transmission).
• Compromised immune system (diabetes, HIV/AIDS, chemotherapy), which can worsen disease severity.

Diagnosis

Early diagnosis is critical because antibiotics are most effective when started within 24 hours of symptom onset.

Clinical evaluation

• History of exposure to rodents or flea‑infested environments.
• Physical exam focusing on buboes, respiratory findings, and signs of sepsis.

Laboratory tests

1. Microscopy: Gram stain of bubo aspirate or sputum shows gram‑negative bipolar (“safety‑pin”) rods.
2. Culture: Growth on selective media (Cefsulodin‑Irgasan‑Novobiocin agar). Cultures take 24–48 h.
3. Polymerase chain reaction (PCR): Rapid detection of Y. pestis DNA from blood, tissue, or sputum; preferred in high‑risk settings.
4. Serology: Detects antibodies (IgM/IgG) after 7–10 days; useful for retrospective diagnosis.
5. Rapid antigen tests: Limited availability but can provide point‑of‑care results.

Imaging (if indicated)

• Chest X‑ray or CT scan for pneumonic plague – may show lobar infiltrates, pleural effusion.
• Ultrasound of enlarged lymph nodes to guide aspiration.

Treatment Options

Antibiotic therapy dramatically reduces mortality when started early.

First‑line antibiotics (recommended by CDC & WHO)

• Streptomycin 1 g intramuscularly every 12 h for 7–10 days.
• Gentamicin 5 mg/kg IV/IM once daily for 7–10 days (alternative to streptomycin).
• Doxycycline 100 mg orally or IV twice daily for 10–14 days (useful for mild cases or when aminoglycosides are contraindicated).
• Ciprofloxacin 500 mg orally twice daily for 10–14 days (effective for both bubonic and pneumonic forms).

Supportive care

• IV fluids and electrolytes for septic shock.
• Oxygen therapy or mechanical ventilation for severe pneumonic plague.
• Pain control for painful buboes (acetaminophen or NSAIDs; avoid high‑dose aspirin if septicemia is suspected).
• Wound care and possible surgical drainage of large buboes.

Adjunctive measures

• Isolation of patients with pneumonic plague (droplet precautions, negative‑pressure rooms).
• Prophylactic antibiotics for close contacts: doxycycline 100 mg daily for 7 days or ciprofloxacin 500 mg twice daily for 7 days.
• Post‑exposure vaccination is not routinely available; research is ongoing.

Lifestyle modifications during treatment

• Rest and adequate nutrition to support immune recovery.
• Avoid smoking and alcohol, which can impair healing.
• Maintain good personal hygiene; keep wound dressings clean.

Living with Yersinia pestis infection (plague)

Even after successful treatment, patients may need ongoing care.

Follow‑up care

• Repeat blood cultures 48 h after starting antibiotics to confirm clearance.
• Clinical reassessment at 2 weeks and again at 1 month to monitor for late complications (e.g., lymphadenitis, pulmonary fibrosis).
• Psychological support: surviving a severe infection can cause anxiety or post‑traumatic stress.

Daily management tips

• Hydration: Aim for 2–3 L of fluid daily unless fluid‑restricted for heart failure.
• Nutrition: High‑protein, vitamin‑rich diet (lean meats, legumes, fruits, vegetables) to aid tissue repair.
• Activity: Light activity (short walks) after the first week; avoid heavy lifting if buboes are still tender.
• Wound care: Change dressings daily, keep the area dry, and watch for signs of secondary infection (redness, increased pus).
• Medication adherence: Complete the full antibiotic course even if you feel better.

Prevention

Because plague is primarily a zoonosis, prevention focuses on limiting human‑rodent‑flea interactions.

Environmental control

• Reduce rodent habitats around homes: keep yards tidy, store firewood off the ground, seal building entry points.
• Use insecticidal dust or rodent‑proof bait stations in endemic areas.
• Maintain pet flea control (monthly topical products or oral ivermectin as prescribed).

Personal protective measures

• Wear thick gloves and a disposable gown when handling dead animals.
• Use a N95 respirator or surgical mask if working in areas with aerosol risk (e.g., during necropsy).
• Wash hands thoroughly with soap and water after any contact with rodents or soil.

Travel & outdoor advice

• Check CDC/WHO health notices before traveling to endemic regions.
• When camping or hiking, avoid sleeping on the ground and use a raised cot.
• Use insect repellent containing DEET or picaridin on exposed skin.

Public health interventions

• Surveillance of rodent populations and flea indices.
• Prompt reporting of human cases to local health departments.
• Community education campaigns during outbreaks.

Complications

If untreated or if treatment is delayed, plague can lead to life‑threatening complications.

• Septic shock – multi‑organ failure, hypotension, DIC.
• Respiratory failure from pneumonic plague.
• Gangrene of extremities due to vascular occlusion in septicemic plague.
• Encephalitis – confusion, seizures, possible permanent neurologic deficits.
• Secondary bacterial infections of buboes or lungs.
• Long‑term pulmonary fibrosis after severe pneumonic infection.

When to Seek Emergency Care

Sources: World Health Organization (WHO) – Plague Fact Sheet 2023; Centers for Disease Control and Prevention (CDC) – Plague (Yersinia pestis) 2022; Mayo Clinic – Plague; National Institutes of Health (NIH) – Antibiotic Therapy for Plague; Cleveland Clinic – Infectious Diseases.

```